Announcing Earth Day Plus (Apr 22 to May 3) – VC-Founder Matchup + Live Sessions. Learn More

Circularis

https://www.ginkgobioworks.com/2022/10/04/acquiring-altar-and-circularis-to-strengthen-our-capabilities/

Team

Paul Feldstein

CEO, President & Co-Founder

LeAnn Lindsay

Founder

James Lincoln

Senior Scientist & Co-Founder

Company details

Circularis has developed a powerful and novel method to regulate gene expression to increase minimum bio-therapeutic production yields by up to ten times. We can do this for any gene in any species with no prior knowledge of the regulatory elements or coding sequence. Circularis is the only company that can deliver optimized gene expression and increased production yields for any protein from any species.

Get In Touch with Circularis

Please tell us a little bit about yourself and why you'd like to get connected. Circularis + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.